Revolution Medicines, Inc. (RVMD) has 20 已知的内部人和机构持有人记录. 最大持有人为 Third Rock Ventures III, L.P. 持有 5,524,031 股. 其他重要持有人包括 TEPPER ROBERT I 和 COLUMN GROUP III, LP.
过去12个月,内部人进行了 46 笔交易,涉及 RVMD 股票 — 9 笔买入 (价值为 $38.84M) 和 24 笔卖出 (价值为 $8.31M). 内部人卖出超过买入.
RVMD 內部人持股
最大持股人
Third Rock Ventures III, L.P.
5,524,031 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Third Rock Ventures Iii, L.p. |
10 Percent Owner |
5,524,031 |
2021-02-26 |
|
| 2 |
Tepper Robert I |
Director |
5,104,130 |
2022-06-10 |
|
| 3 |
Column Group Iii, Lp |
10 Percent Owner |
2,151,026 |
2020-11-18 |
|
| 4 |
Svennilson Peter |
Director |
1,582,965 |
2021-04-28 |
|
| 5 |
Schroeder Thilo |
Director |
760,869 |
2024-12-09 |
|
| 6 |
Kelsey Stephen Michael |
See Remarks |
295,398 |
2026-03-19 |
|
| 7 |
Goldsmith Mark A |
See Remarks |
276,698 |
2026-03-19 |
|
| 8 |
Third Rock Ventures Ii, L.p. |
10 Percent Owner |
164,996 |
2021-06-07 |
|
| 9 |
Horn Margaret A |
Chief Operating Officer |
157,570 |
2026-03-19 |
|
| 10 |
Anders Jack |
Chief Financial Officer |
125,512 |
2026-03-19 |
|
| 11 |
Wang Xiaolin |
See Remarks |
116,063 |
2026-03-19 |
|
| 12 |
Wei Lin |
Chief Medical Officer |
101,366 |
2026-03-19 |
|
| 13 |
Cislini Jeff |
General Counsel |
59,681 |
2026-03-19 |
|
| 14 |
Mancini Anthony |
See Remarks |
54,400 |
2026-03-26 |
|
| 15 |
Lasky Laurence |
Director |
36,168 |
2020-02-14 |
|
| 16 |
Clyburn Frank |
Director |
26,540 |
2025-04-28 |
|
| 17 |
Schmidt Eric Thomas |
Director |
18,400 |
2023-06-12 |
|
| 18 |
Exter Neil |
Director |
18,400 |
2022-06-17 |
|
| 19 |
Kim Lorence H. |
Director |
15,955 |
2024-06-28 |
|
| 20 |
Borisy Alexis |
Director |
15,955 |
2024-06-28 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-03-25 |
Mancini Anthony |
See Remarks |
知情卖出 |
400 |
$97.21 |
$38.88K |
| 2026-03-20 |
Mancini Anthony |
See Remarks |
未知 |
26,200 |
$102.02 |
$2.67M |
| 2026-03-20 |
Sandler Alan B. |
Chief Development Officer |
未知 |
11,700 |
$102.02 |
$1.19M |
| 2026-03-19 |
Cislini Jeff |
General Counsel |
知情卖出 |
1,163 |
$97.44 |
$113.32K |
| 2026-03-17 |
Cislini Jeff |
General Counsel |
知情卖出 |
1,795 |
$99.48 |
$178.57K |
| 2026-03-17 |
Wei Lin |
Chief Medical Officer |
知情卖出 |
2,073 |
$99.48 |
$206.22K |
| 2026-03-17 |
Wang Xiaolin |
See Remarks |
知情卖出 |
2,010 |
$99.48 |
$199.96K |
| 2026-03-17 |
Anders Jack |
Chief Financial Officer |
知情卖出 |
2,753 |
$99.48 |
$273.87K |
| 2026-03-17 |
Kelsey Stephen Michael |
See Remarks |
知情卖出 |
4,302 |
$99.48 |
$427.96K |
| 2026-03-17 |
Horn Margaret A |
Chief Operating Officer |
知情卖出 |
4,583 |
$99.48 |
$455.92K |
| 2026-03-17 |
Goldsmith Mark A |
See Remarks |
知情卖出 |
12,871 |
$99.48 |
$1.28M |
| 2026-03-04 |
Anderson Elizabeth M |
Director |
赠与(送出) |
15,000 |
- |
- |
| 2026-03-01 |
Cislini Jeff |
General Counsel |
限制性股票授予 (RSU) |
32,500 |
$102.02 |
$3.32M |
| 2026-03-01 |
Wei Lin |
Chief Medical Officer |
限制性股票授予 (RSU) |
34,000 |
$102.02 |
$3.47M |
| 2026-03-01 |
Wang Xiaolin |
See Remarks |
限制性股票授予 (RSU) |
34,000 |
$102.02 |
$3.47M |
| 2026-03-01 |
Anders Jack |
Chief Financial Officer |
限制性股票授予 (RSU) |
45,400 |
$102.02 |
$4.63M |
| 2026-03-01 |
Kelsey Stephen Michael |
See Remarks |
限制性股票授予 (RSU) |
47,600 |
$102.02 |
$4.86M |
| 2026-03-01 |
Horn Margaret A |
Chief Operating Officer |
限制性股票授予 (RSU) |
47,600 |
$102.02 |
$4.86M |
| 2026-03-02 |
Goldsmith Mark A |
See Remarks |
期权行权(卖出) |
30,000 |
$4.09 |
$122.7K |
| 2026-03-01 |
Goldsmith Mark A |
See Remarks |
限制性股票授予 (RSU) |
128,600 |
$102.02 |
$13.12M |
| 2026-02-06 |
Goldsmith Mark A |
See Remarks |
期权行权(卖出) |
24,010 |
$0.54 |
$12.97K |
| 2026-01-21 |
Cislini Jeff |
General Counsel |
知情卖出 |
908 |
$115.60 |
$104.96K |
| 2026-01-07 |
Anders Jack |
Chief Financial Officer |
期权行权(卖出) |
10,000 |
$42.45 |
$424.5K |
| 2026-01-07 |
Horn Margaret A |
Chief Operating Officer |
期权行权(卖出) |
51,406 |
$42.45 |
$2.18M |
| 2025-12-16 |
Cislini Jeff |
General Counsel |
知情卖出 |
2,688 |
$76.82 |
$206.48K |